RVRTXVertex Pharmaceuticals Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
S. biopharmaceutical enterprise engaged in the development and commercialization of prescription drugs. Its primary approved products are used to treat cystic fibrosis. Additionally, the company has clinical-stage product candidates in sickle cell disease, thalassemia, acute pain, and specific kidney diseases.
- Macro context: RVRTX is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
+7.18%
14D
+10.12%
30D
—
1Y
—
All-time
+7.45%
Market Cap
$3.09K
24h Volume
$4.78K
On-Chain Holders
2
Summed across all deployed chains (per-chain wallets not de-duplicated)
Key facts
via /coins/{id}Market Cap Rank
#14812
Circulating Supply
5.57
Total Supply
5.57
All-Time High
$587.58 · 2026-11-02
Categories
News & Insights
Also tokenized by
Vertex Pharmaceuticals Tokenized Stock (Reality) is issued as 3 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| Ondo Finance | $557.63 | $8.23K | $125.96 |    | |
| xStocks | VRTVRTXX | — | — | — | — |
VRTXONAlerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RVRTX crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RVRTX — the second it drops.
Daily summary
A once-a-day digest of RVRTX's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RVRTX — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RVRTX paired with the latest issuer, regulatory and market news.